Haijiao Jing Selected Research

((3- (bis(2- chloroethyl)amino)- 4- methylphenyl)hydroxymethane)bisphosphonic acid

1/2021

Phosphatidylserine-exposing tumor-derived microparticles exacerbate coagulation and cancer cell transendothelial migration in triple-negative breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haijiao Jing Research Topics

Disease

6	Thrombosis (Thrombus) 01/2022 - 01/2020
5	COVID-19 01/2022 - 01/2020
3	Inflammation (Inflammations) 01/2022 - 01/2020
3	Thrombophilia 01/2022 - 01/2020
2	Hypoxia (Hypoxemia) 01/2022 - 01/2021
2	Infections 01/2022 - 01/2020
2	Neoplasms (Cancer) 01/2021 - 01/2021
1	Fibrosis (Cirrhosis) 01/2022
1	Periodontitis 01/2022
1	Lung Injury 01/2022
1	Vascular Remodeling 01/2022
1	Thromboembolism 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Cytokine Release Syndrome 01/2021
1	Pulmonary Hypertension 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Ischemic Stroke 01/2021
1	Hemorrhage 10/2020
1	Critical Illness (Critically Ill) 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

7	PhosphatidylserinesIBA 01/2022 - 01/2020
4	CytokinesIBA 01/2022 - 01/2020
3	Fibrinogen (Factor I)FDA Link 01/2021 - 10/2020
1	prothrombinase complexIBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Thromboplastin (Tissue Factor)IBA 01/2022
1	GlobulinsIBA 01/2021
1	Fibrinolysin FDA Link 01/2021
1	((3- (bis(2- chloroethyl)amino)- 4- methylphenyl)hydroxymethane)bisphosphonic acidIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	AnticoagulantsIBA 01/2021
1	AlbuminsIBA 01/2021
1	adhesion receptorIBA 10/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Pharmaceutical PreparationsIBA 01/2020

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2020
1	Thrombolytic Therapy 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Intravenous Injections 01/2021
1	Neoadjuvant Therapy 01/2021
1	Hemofiltration 01/2020